Prosecution Insights
Last updated: November 05, 2026

Panoptic AG Solutions LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Panoptic AG Solutions LLC has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. This prosecution activity involves 2 distinct examiners and 2 distinct art units. The use of these 2 distinct examiners for the pending actions suggests a lack of examiner continuity, requiring the applicant to navigate different individual preferences for each case.

ISNOR, ALEXANDRA NICOLE is the busiest examiner for the company, holding 1 pending office action. The presence of 2 distinct art units for only 2 pending actions reflects a fragmented examination landscape for the current portfolio. This distribution implies that the subject matter of the pending office actions is diverse enough to fall under different supervisory groups. Practitioners should be prepared for the 2 distinct examiners to apply different standards of evidence or prior art interpretations during the prosecution of these biotechnology applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ISNOR, ALEXANDRA NICOLE 1 26.1% +26.2%
LANGEL, WAYNE A 1 78.3% +23.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17956221 UREA CYCLE AUGMENTING COMPOSITION AND METHODS OF USE LANGEL, WAYNE A 69d
18074271 PLANT METABOLISM PROMOTING COMPOSITIONS AND METHODS OF USE ISNOR, ALEXANDRA NICOLE —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17956221 UREA CYCLE AUGMENTING COMPOSITION AND METHODS OF USE LANGEL, WAYNE A 69d
18074271 PLANT METABOLISM PROMOTING COMPOSITIONS AND METHODS OF USE ISNOR, ALEXANDRA NICOLE —

Top Art Units

Art UnitApps
1611 1
1736 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18074271 PLANT METABOLISM PROMOTING COMPOSITIONS AND METHODS OF USE ISNOR, ALEXANDRA NICOLE 1611 §103DP Non-Final OA — Pending Dec 02, 2022
17956221 UREA CYCLE AUGMENTING COMPOSITION AND METHODS OF USE LANGEL, WAYNE A 1736 §102§103 Non-Final OA 69d Pending Sep 29, 2022

Managing Panoptic AG Solutions LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Panoptic AG Solutions LLC have?

Panoptic AG Solutions LLC has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Panoptic AG Solutions LLC applications?

Alexandra Nicole Isnor has the most, with 1 of Panoptic AG Solutions LLC's pending office actions.

What technology area are Panoptic AG Solutions LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month